Nam Ha Pharma continues to be listed among the Top 500 Largest Enterprises in Vietnam (VNR500) 2025, marking 12 consecutive years of presence in this prestigious ranking and further affirming the company’s sustainable development capability and long-term strategic orientation.

The VNR500 ranking is built on the Fortune 500 model, based on independent research and evaluation conducted in accordance with international standards by Vietnam Report, with consultation from domestic and international economic experts. Maintaining a position in the ranking for more than a decade not only reflects operational scale, but also demonstrates Nam Ha Pharma’s ability to sustain operational efficiency across multiple periods of economic volatility.

Chairman of the Board of Directors of Nam Ha Pharma receiving the Award

Internal Strength Reflected Through a Product Ecosystem

The internal strength of Nam Ha Pharma has been formed through a long-term accumulation process and is clearly reflected in its end-to-end operational capabilities across the value chain. The company has developed a diverse product ecosystem, including modern pharmaceuticals, traditional medicines, and health supplements, addressing essential healthcare needs of the population.

Among these, many products have established a sustainable market presence and long-term consumer trust, such as Bo Phe Nam Ha, Coldi-B Nam Ha Nasal Spray, Skinbibi Children’s Skin Cream, along with various treatment and supportive medicines widely distributed through pharmacies and hospitals nationwide.

Amid rising input costs and increasingly stringent standardization requirements, Nam Ha Pharma remains steadfast in prioritizing quality, making systematic investments in manufacturing systems and operational processes under strict management standards. This serves as a critical foundation enabling the company to maintain product stability and enhance long-term competitiveness.

At the same time, a nationwide distribution network allows Nam Ha Pharma to maintain stable market access, create sustainable growth momentum, and mitigate risks from short-term market fluctuations.

Selected key products of Nam Ha Pharma

Sustainable Development Aligned with Long-Term Orientation

Beyond maintaining existing product lines, Nam Ha Pharma is gradually implementing a structured and comprehensive strategy for the development of traditional medicine. This orientation is reflected in the standardization of raw material areas, increased investment in research and development, and the step-by-step enhancement of manufacturing processes toward higher quality standards, with a focus on cGMP.

This approach enables the company to leverage the traditional strengths of herbal medicine while meeting modern consumer trends and the sustainable development requirements of the pharmaceutical industry in a new phase. Choosing selective growth rather than rapid expansion at all costs helps Nam Ha Pharma maintain stability and sustainability in the medium and long term.

As the pharmaceutical industry enters a phase of strong restructuring and standardization, Nam Ha Pharma’s long-term, prudent yet persistent development orientation is considered a significant advantage. This foundation enables the company to maintain a stable position, strengthen competitiveness, and progressively elevate brand value in the next stage of development.

Social Responsibility Accompanying Growth

In addition to its business operations, Nam Ha Pharma identifies social responsibility not as a peripheral activity, but as an integral part of its long-term development strategy. The company remains committed to its core value of placing people at the center, viewing sustainable development as something that must begin from within and from its workforce.

Nam Ha Pharma focuses on building a stable workforce, with synchronized implementation of training, welfare, and human resource development policies, contributing to enhanced professional capacity and forming a solid foundation for sustainable operations.

At the same time, the company proactively integrates business activities with community responsibility through healthcare support programs, public health initiatives, and charitable activities. In 2025, Nam Ha Pharma participated in and supported numerous community initiatives, including: providing aid to flood-affected residents in Dak Lak Province; contributing support to the people of Cuba; participating in the “Medicine Cabinets for Children” project; and accompanying free medical check-ups, health consultations, and medicine distribution programs across many provinces and cities nationwide.

Nam Ha Pharma implements numerous practical activities demonstrating social responsibility

The social responsibility initiatives of Nam Ha Pharma are implemented flexibly and promptly, originating from the actual needs of the community, thereby clearly demonstrating the role and responsibility of an enterprise operating in the healthcare sector.

Nam Ha Pharma’s continued presence in the Top 500 Largest Enterprises in Vietnam 2025, along with other prestigious honors such as Vietnam National Brand, Top 5 Reputable Traditional Medicine Companies, Top 10 Leading Value-Creating Enterprises in Vietnam – Pharmaceutical & Medical Equipment, High-Quality Vietnamese Goods, among others, reflects consistent market recognition of the company’s long-term value creation capability.

This is not only a summary of achieved results, but also a reflection of market expectations for Nam Ha Pharma’s pillar role in the sustainable development of Vietnam’s pharmaceutical industry and the national economy in the next phase – centered on quality, internal strength, and long-term value.